The prolyl oligopeptidase inhibitor KYP-2047 is not readily bioavailable to bloodstream form trypanosomes and human myelocytic leukemia cells
published in: Journal of Pharmaceutical Negative Results
date of publication: 2015
main subject: leukemia
Cites articles
There is nothing here
Article - wd:Q58854979